Thank You!
Thank you for your email subscription. Check your email to get Coupon Code.
Blue Ocean Strategy of Amylin Pharmaceuticals B
Posted by Matthew Harvey on Mar-29-2023
Introduction
The blue ocean strategy refers to a situation or a market where there is no irrelevant competition, or where there is negligible competition. The blue ocean strategy of Amylin Pharmaceuticals B is focused on searching for new markets and business avenues which operate with minimal pricing pressures. The blue ocean strategy can be applied across different sectors and industries, and the businesses that exist within them. Amylin Pharmaceuticals B blue ocean strategy is pivoted on entering new market spaces, or developing them as well as on innovation focused internally or externally that helps reinvent the industry to ensure no irrelevant competition (Kim & Mauborgne, 2014).
Moving away from saturated markets
The Amylin Pharmaceuticals B continues to operate in saturated market spaces, and is restricted in growth and expansion. The Amylin Pharmaceuticals B’s businesses often face hurdles in the way of development and are also faced with increasingly intense pricing pressures- and are thus said to operate in a red ocean. A red ocean is marked with cut-throat competition and pricing wars that compromise the profits for all players. Pressures in saturated markets along with narrow growth spaces had forced the Amylin Pharmaceuticals B to search for new avenues – vertically or horizontally – to be able to enjoy higher market shares, and swim in blue oceans (Kim & Mauborgne, 2014).
Blue ocean strategy and differentiation
New industry boundaries
As companies and organizations move towards blue oceans, they redraw and redesign industry boundaries. This is possible through innovation and creativity. The Amylin Pharmaceuticals B also explores new platforms and channels, as well as means of doing business and is thus able to expand existing industry boundaries. The Amylin Pharmaceuticals B has also been able to show the potential of developing new industries through its innovations – by identifying new spaces and making the competition irrelevant (Agnihotri, 2016).
Differentiation
The Amylin Pharmaceuticals B has focused on differentiation under the blue ocean strategy. The Amylin Pharmaceuticals B’s efforts towards differentiation are focused on creating unique value for the customers in its product and service offerings (Agnihotri, 2016; Blue Ocean Strategy, 2022).
Cost efficiencies and low cost
Under blue oceans, the Amylin Pharmaceuticals B also focuses on maintaining affordability for the value additions and differentiated products and services that it offers. The Amylin Pharmaceuticals B commonly continuously reevaluates and reassesses its own processes and systems to maintain high-cost efficiencies (Freedman, 2022).
Value innovation – value addition and low-cost maintenance
In doing so, the Amylin Pharmaceuticals B has been able to explore blue oceans through value additions as well as affordability for consumers. The Amylin Pharmaceuticals B has been able to successfully identify what consumer’s value and include it in its offerings and value propositions. At the same time, the Amylin Pharmaceuticals B has been able to provide the value differentiation at affordable costs. In this manner, the Amylin Pharmaceuticals B enjoys high levels of value innovation (Kim, 2002; Kim & Mauborgne, 2014).
Understanding red oceans
Under red oceans, where the Amylin Pharmaceuticals B previously operated, all layers had accepted the predefined structures and boundaries of the industry, and had continued to operate as well as compete within these (The Economic Times, 2022).
Cut throat competition
To be able to remain profitable and successful, players, including the Amylin Pharmaceuticals B within red oceans, focused efforts on developing and maintaining competitive advantages over one another, and other players. This advantage was largely cost-based, as in the case of the Amylin Pharmaceuticals B. In this way, wealth was only redistributed at the expense of other players, and the Amylin Pharmaceuticals B failed to create any new wealth in the red oceans (Kim & Mauborgne, 2005).
Understanding blue oceans
Under the blue ocean strategy, the Amylin Pharmaceuticals B operates in an industry and market space that is not marked with set boundaries or structures. These blue ocean structures have been recreated by the Amylin Pharmaceuticals B at large, as well as by other players. Other players have also contributed to the restructuring of the industry through innovation (Kim & Mauborgne, 2014).
Restructuring industrial boundaries under the blue ocean strategy
Under the blue ocean strategy, the Amylin Pharmaceuticals B is not restricted by predefined rules, barriers, and principles. Instead, the Amylin Pharmaceuticals B has been able to shift its strategic direction and attention from focusing on supply towards working on developing and creating demand (Blue Ocean Strategy, 2022). The Amylin Pharmaceuticals B, in this manner, is focused on the building of value innovation in its offerings, along with ensuring efforts towards building and maintaining differentiation and cost-effectiveness. In this way, the Amylin Pharmaceuticals B has been able to immaterialize the competition (Kim & Mauborgne, 2017).
Strategic directions for blue oceans
The Amylin Pharmaceuticals B has four different strategic directions, which it can choose from four continuing to pursue its blue ocean strategy. All of these strategic directions will strengthen the company’s current business position and will supports its strategy of value addition and cost efficiencies, as well as differentiation – allowing it to develop strong and sustainable market positions. These directions are
Raise
-
The Amylin Pharmaceuticals B should assess and evaluate the current industry standards and practices.
-
The Amylin Pharmaceuticals B should identify loopholes, and areas which can be improved, expanded upon, or developed a new within the industry.
-
The Amylin Pharmaceuticals B should identify different drivers and factors within the industry boundaries.
-
The Amylin Pharmaceuticals B should identify through research and observation the different factors that could raise above the existing industry standards (Kim, 2002; Kim & Mauborgne, 2017).
Eliminate
-
The Amylin Pharmaceuticals B should assess and observe current industry standards.
-
The Amylin Pharmaceuticals B should observe players’ practices within the industry, and relate the same with the industry standards.
-
The Amylin Pharmaceuticals B can identify the standards which are not needed, which are obsolete, and which may slow down operations and processes.
-
These standards can be eliminated in own operations by the Amylin Pharmaceuticals B (Kim & Mauborgne, 2014; Freedman, 2022).
Reduce
-
The Amylin Pharmaceuticals B can also assess an observe industry standards for identifying factors that are not needed, or needed partially.
-
The Amylin Pharmaceuticals B can work on reducing these standards to enhance operational performance and maximum utilization of resources as well as value addition (The Economic Times, 2022; Kim & Mauborgne, 2014).
Created
-
The Amylin Pharmaceuticals B can also expand current industry boundaries and standards.
-
This expansion will be possible by the Amylin Pharmaceuticals B through expanding and creating new standards.
-
The new standards can be created by the Amylin Pharmaceuticals B through observing industry processes and operations, and identifying potential loopholes.
-
The Amylin Pharmaceuticals B can introduce new processes and standards to redesign industry boundaries (Agnihotri, 2016; Kim & Mauborgne, 2005).
Blue ocean strategy: organizational competencies
The Amylin Pharmaceuticals B has been able to successfully implement the blue ocean strategy because of three important organizational elements (Freedman, 2022). These organizational elements have allowed the Amylin Pharmaceuticals B to explore blue oceans, experiment successfully with innovation, and add value to its product offerings. These elements include the following:
Mindset
-
The Amylin Pharmaceuticals B has a progressive mindset that is rooted in this participative and visionary leadership (Bratton, 2020).
-
The Amylin Pharmaceuticals B has a positive and can-do attitude and mindset.
-
This mindset has allowed the Amylin Pharmaceuticals B to achieve success through high focus and efforts (Wilson, 2018).
-
The Amylin Pharmaceuticals B has high motivation levels of employees – which enhances the optimal performance of the organization and has allowed it to explore Blue Ocean through creativity (Kim & Mauborgne, 2017; Kim & Mauborgne, 2005; Wilson, 2018).
Tools
-
The Amylin Pharmaceuticals B has access to multiple resources that has allowed it to take advantage of the blue ocean strategy (Mebert & Lowe, 2017).
-
These resources Amylin Pharmaceuticals B capabilities are internal as well as external for the Amylin Pharmaceuticals B.
-
The Amylin Pharmaceuticals B has also invested resources and trainings for developing internal capabilities and capacities for ensuring upgraded skills and increased value addition (Buchanan & Huczynski, 2019; Chernev, 2018).
Culture
-
The Amylin Pharmaceuticals B has a learning culture, and encourages all employees to ask questions and carry out healthy discussions (Anthony, 2021; Schein, 2010).
-
The Amylin Pharmaceuticals B has a culture that is focused on research and development, which in turn leads to new innovations and solutions for existing demands and challenges (Wunder, 2019).
-
The Amylin Pharmaceuticals B has an inclusive and diverse culture, which leads to increased synergies that allow the development and implementation of blue ocean strategies easily (Wilson, 2018).
Using the blue ocean strategy effectively: steps for successful implementation
The Amylin Pharmaceuticals B has developed the blue ocean strategy following systematic and organized processes and steps (Kim & Mauborgne, 2017). The steps that the Amylin Pharmaceuticals B undertook for developing the blue ocean strategy include:
Step1
The Amylin Pharmaceuticals B conducted thorough market and industry research to identify the right place to work towards developing a core team (Kim & Mauborgne, 2014; Freedman, 2022). This core team was responsible for driving Amylin Pharmaceuticals B forward strategically towards new value additions and differentiations (Blue Ocean Strategy, 2022; Kim & Mauborgne, 2017 b).
Step2
The Amylin Pharmaceuticals B continued to conduct deep market analysis as well as studied and assessed the competition closely. This was needed by the Amylin Pharmaceuticals B to identify potential opportunities, and demand gaps in the existing industry as well as potential structural changes in the existing industrial boundaries (Blue Ocean Strategy, 2022).
Step3
The Amylin Pharmaceuticals B’s assessment of the macro environment, and the market spaces allowed it to also identify the challenges and issues hidden in the current industry structure and design (Machado, 2019; Kim & Mauborgne, 2017 b). These issues and problems have restricted the industry size, and led to restrictive growth for the Amylin Pharmaceuticals B. The Amylin Pharmaceuticals B was also blue to identify new non-customers in this assessment- which could be turned into future consumers (Blue Ocean Strategy, 2022).
Step4
The Amylin Pharmaceuticals B worked to redesign and reconstruct the industry boundaries and structures in a systematic manner. This was done through identifying new opportunities, as well as through exploring new innovations and valuations in existing offerings (Blue Ocean Strategy, 2022).
Step5
The Amylin Pharmaceuticals B finally elected the right blue ocean move, i.e. conducted various pilot testing’s and market testing for its new offerings before finalizing and launching them in the market to attract new consumers, and explore new markets (Blue Ocean Strategy, 2022).
Tackling challenges on the way to Blue Ocean
Restructuring and reorganizing the boundaries and structures of the industries is not that simple (Anthony, 2021; Kim & Mauborgne, 2017 b). Managers and practitioners of the Amylin Pharmaceuticals B seek to renew the value of their offerings within the organization – mostly using new technologies and advances networks to not only create value propositions, but also transform existing ones (Kim & Mauborgne, 2005; Kim, 2002). However, the Amylin Pharmaceuticals B has been able to overcome resistance towards change and innovation within the organization, as well as in the external environments, because of:
Organizational culture
The culture within the Amylin Pharmaceuticals B supports exploration and innovation. This culture is important for supporting the development and implementation of new ideas that boost the value propositions of the Amylin Pharmaceuticals B (Chernev, 2018; Bratton, 2020; Martinez, Beaulieu, & Gibbons, 2015).
Business design
The Amylin Pharmaceuticals B also continually practices business design (Freedman, 2022). The Amylin Pharmaceuticals B ensures that it’s leading from the font. This means that the Amylin Pharmaceuticals B ensures that its teams are empowered, and confident in tackling ambiguous and difficult challenges and issues. This allows the Amylin Pharmaceuticals B to identify new opportunities and innovate (Wunder, 2019).
Strong and visionary leadership
The Amylin Pharmaceuticals B has a forward-thinking, progressive, charismatic leadership. This leadership ensures that the Amylin Pharmaceuticals B continually engages in disruptive processes and innovations – which in turn allow the company to explore and implement the blue ocean strategy. The leadership is supportive of, and facilitates the change processes within the company (Machado, 2019).
Communication
The Amylin Pharmaceuticals B ensures that all communication within the organization is transparent and quick (Chernev, 2018; Buchanan & Huczynski, 2019). The leadership and management levels have frequent meetings within the company along managerial levels (Wilson, 2018; Wunder, 2019). This allows employees to feel on board of the happenings, and be part of a change from the beginning – understanding its need and facilitating its implementation. This is critical for ensuring successful innovation and adoption of the blue ocean strategy (Anthony, 2021; Chernev, 2018; Kim, 2002).
Value innovation in blue ocean strategy
Value innovation within the blue ocean strategy focuses on value as well as innovation (Blue Ocean Strategy, 2022; Kim & Mauborgne, 2017). This means that the Amylin Pharmaceuticals B seeks to innovate and create value at the same time as a means of differentiation within the marketplace to be able to implement the blue ocean strategy (Kim & Mauborgne, 2014). The Amylin Pharmaceuticals B does not only engage in value creation – which focuses on scaling the existing value only instead of creating a new one (Blue Ocean Strategy, 2022; Agnihotri, 2016; Kim & Mauborgne, 2014).
Technology innovation
The Amylin Pharmaceuticals B engages in value innovation through technology innovation. The Amylin Pharmaceuticals B ensures that it uses advanced and progressive technology to address various consumer demands and problems as well as needs in innovative ways and manners (Kim & Mauborgne, 2005). However, the Amylin Pharmaceuticals B ensures that it focuses on value innovation rather than technology innovation in its value propositions so that new value through technology is created for consumers (Kim, 2002; Wilson, 2018).
Low cost
The Amylin Pharmaceuticals B also ensures affordability with value innovation. The value innovation allows the Amylin Pharmaceuticals B to operate at low costs, and maintain cost efficiencies (Chernev, 2018). As a result, the Amylin Pharmaceuticals B maintains low costs and high value for consumers – allowing it to tap into new consumer groups as well. As a result, the Amylin Pharmaceuticals B is able to enjoy a high growth rate as well as increased sales and profits (Kim & Mauborgne, 2014).
The strategies and strategic directions for designing and implementing the blue ocean strategy have been overseen through some guiding and fundamental principles by the Amylin Pharmaceuticals B. These include”
Formulation principles
Redesigning the industry
-
The Amylin Pharmaceuticals B sought to reconstruct, redesign and rebuild the market boundaries and standards.
-
The Amylin Pharmaceuticals B was bold enough to redefine the industry space and the market space in which it operated (Mebert & Lowe, 2017).
Long term focus
-
The Amylin Pharmaceuticals B focused on long-term success and sustainability, instead of short-term gains and numbers.
-
The Amylin Pharmaceuticals B was visionary, and aw beyond the existent customer demand and needs (Freedman, 2022).
Demand creation
-
The Amylin Pharmaceuticals B creates demand for the new value-added offerings it manufactured and proposed in the blue oceans (Kim, 2002).
-
The Amylin Pharmaceuticals B tapped into new customer groups and target audiences (Kim & Mauborgne, Red Ocean Traps (Harvard Business Review Classics), 2017 b).
Execution principles
Overcoming organizational challenges
Organizational culture
-
The Amylin Pharmaceuticals B has a result organizational culture (Martinez, Beaulieu, & Gibbons, 2015; Schein, 2010).
-
The Amylin Pharmaceuticals B invests in research and development.
-
The Amylin Pharmaceuticals B is quick to adapt to change and has a disciplined change management team to oversee change processes (Chernev, 2018; Kim & Mauborgne, 2014).
Environmental assessment
-
The Amylin Pharmaceuticals B continually assesses its internal and external environments and creates contingency plans (Chernev, 2018; Machado, 2019).
-
The Amylin Pharmaceuticals B engages in pre-strategic planning to help strengthen its strategic focus and direction (Wilson, 2018; Kim & Mauborgne, 2017 b).
Leadership
-
The Amylin Pharmaceuticals B has a visionary leadership (Bratton, 2020).
-
The leadership at the Amylin Pharmaceuticals B has a participative approach which encourages employee motivation and their organizational commitment.
-
The leadership ensures optimal organizational performance at the Amylin Pharmaceuticals B (Freedman, 2022; Kim & Mauborgne, 2005).
Developing execution strategy
-
The Amylin Pharmaceuticals B has developed a sequential strategic direction for execution.
-
The execution of the blue ocean strategy is based on market research (Anthony, 2021).
-
The execution of the blue ocean strategy has been carefully planned to ensure that it’s timely.
-
The execution involves all parts and members of the Amylin Pharmaceuticals B (The Economic Times, 2022; Kim, 2002).
Blue ocean strategic Tools
The Amylin Pharmaceuticals B has been able to use multiple operational and strategic tools.
Shift in organizational mindset
These tools kits have been important for the Amylin Pharmaceuticals B in helping it develop the right mindset needed for aligning processes and systems towards the blue ocean strategic direction (Kim & Mauborgne, 2017 b). The tools have been a powerful source for the Amylin Pharmaceuticals B in facilitating it towards aligning its resources, and identifying potential blue oceans (Kim, 2002). The Amylin Pharmaceuticals B has been diligent in ensuring that its teams and organizational members are familiar with the blue can strategies and tools so that the shift in their mindset is facilitated and strengthened (Wunder, 2019).
Cultural driver
Moreover, the tools also ensure increased alignment of the Amylin Pharmaceuticals B’s culture with the strategy. This, in turn, has allowed the Amylin Pharmaceuticals B to realize the increased number of opportunities, and embed creativity in its internal processes and systems (Kim, 2002; Buchanan & Huczynski, 2019).
These tools include, for example:
-
Value innovation
-
Six path framework
-
Strategy canvas
-
Four action framework
-
Tipping point leadership
-
ERRC Grid
-
Pioneer settler migrator map
-
Buyer utility map
-
3 tiers of non-customers
-
Fair processes
-
Visualizing strategy (The Economic Times, 2022)
Conclusion
With the use of the blue ocean strategy, the Amylin Pharmaceuticals B has been able to redesign the industrial boundaries and standards using multiple techniques and tools that have been identified and discussed briefly in this paper.
The blue ocean strategy has been an important strategic element for the Amylin Pharmaceuticals B. The Amylin Pharmaceuticals B has been able to explore new markets and tap into new customer groups through using the blue ocean strategy. This has been possible for the Amylin Pharmaceuticals B through continuous investment in research and development as well as through its organizational cultural, which is focused on innovation and creativity. The Amylin Pharmaceuticals B has been able to make use of innovative processes and progressive technology to create value innovation. At the same time, the Amylin Pharmaceuticals B has moved out of red oceans and no longer competes over pricing strategies. This has also allowed Amylin Pharmaceuticals B to build a cost advantage, and maintain affordability in its offerings for customers.
References
Agnihotri, A. (2016). Extending boundaries of blue ocean strategy. Journal of Strategic Marketing, 24 (6), 519-528.
Anthony, H. (2021). Understanding strategic management. New York: Oxford University Press.
Blue Ocean Strategy. (2022). WHAT IS BLUE OCEAN STRATEGY? Retrieved 2022, from Blue Ocean Strategy: https://www.blueoceanstrategy.com/what-is-blue-ocean-strategy/
Bratton, J. (2020). Organizational leadership. Newcastle upon Tyne: Sage.
Buchanan, D., & Huczynski, A. (2019). Organizational behaviour. London: Pearson UK.
Chernev, A. (2018). Strategic marketing management. Berlin/Heidelberg: Cerebellum Press.
Freedman, M. (2022). Blue Ocean Strategy: Creating Your Own Market . Retrieved 2022, from https://www.businessnewsdaily.com/5647-blue-ocean-strategy.html
Kim, W. (2002). Blue ocean strategy: from theory to practice. California management review, 47 (3), 105-121.
Kim, W., & Mauborgne, R. (2005). Value innovation: a leap into the blue ocean. Journal of business strategy .
Kim, W., & Mauborgne, R. (2014). Blue ocean strategy, expanded edition: How to create uncontested market space and make the competition irrelevant. Boston, Massachusetts: Harvard business review Press.
Kim, W., & Mauborgne, R. (2017 b). Red Ocean Traps (Harvard Business Review Classics). Boston, Massachusetts: Harvard Business Review Press.
Kim, W., & Mauborgne, R. (2017). Blue ocean leadership (Harvard business review classics). Boston, Massachusetts, United States: Harvard Business Review Press.
Machado, C. (2019). Organizational Behaviour and Human Resource Management. Berlin: Springer.
Martinez, E., Beaulieu, N., & Gibbons, R. (2015). Organizational culture and performance. American economic review, 105 (5), 331-35.
Mebert, A., & Lowe, S. (2017). Blue Ocean Strategy. Literary Criticism.
Schein, E. (2010). Organizational culture and leadership. Hoboken, New Jersey: John Wiley & Sons.
The Economic Times. (2022). What is 'Blue Ocean Strategy' . Retrieved 2022, from https://economictimes.indiatimes.com/definition/blue-ocean-strategy
Wilson, F. (2018). Organizational behaviour and work: a critical introduction. New York: Oxford university press.
Wunder, T. (2019). Rethinking strategic management: Sustainable strategizing for positive impact. Berlin: Springer Nature.
Related Article
- PESTEL Analysis of Amylin Pharmaceuticals B
- Hofstede Cultural Model of Amylin Pharmaceuticals B
- Net Present Value (NPV) Analysis of Amylin Pharmaceuticals B
- Marketing Mix (4Ps) Analysis of Amylin Pharmaceuticals B
- Corporate Social Responsibility of Amylin Pharmaceuticals B
- Amylin Pharmaceuticals B Discounted Cash Flow (DCF) Analysis
- VRIO Analysis of Amylin Pharmaceuticals B
- Amylin Pharmaceuticals B Case Solution
- Marketing Strategy for Amylin Pharmaceuticals B
Latest Feedback
Chiara Mario
Verified
Asked them to edit my assignment and this service did a great job. The writer almost rewrite the 70% of paper. Thank you so much!
Khina Pradhan
Verified
With a dark memory of my senior when she didn’t submit her assignment and was dropped from the semester, I appointed this service. I still remember the hopelessness of her eyes...uff..! The paper that was given to me needed the correction of only 2 full stops. Thanks for letting me make the way progressively from the semester!
Gejo Qin
Verified
I'm lucky one that I got this service and getting good grades with its help. Thanks!
Aria Jonathan
Verified
I was doubtful that might be they can’t write a detailed dissertation in a little time so I gave them a deadline of two months. I received the assignment on time and didn’t get any mistakes in the work. Thanks a lot!
Joimy Obispo
Verified
I would like to say that this service is doing a grand work for students. Prices are good enough that I can set out from the pocket money. Hat tip!
William Lachie
Verified
It's the first one that I found here. The reason why I've rated it with five stars is it provided me good discounts. Much thanks!
Calculate the Price of Your Order
Next Article
- Guidant: Radiation Therapy Blue Ocean Strategy
- Conor Medsystems Blue Ocean Strategy
- Building an Integrated Biopharma Company: Crucell (A) Blue Ocean Strategy
- Joint Juice, Spanish Version Blue Ocean Strategy
- GSK's Acquisition of Sirtris: Independence or Integration? Blue Ocean Strategy
- Fred Khosravi and AccessClosure Blue Ocean Strategy
- LAE Enterprises Corp. Blue Ocean Strategy
- OncoMed Pharmaceuticals: Novel Anti-Cancer Stem Cell Therapeutics Blue Ocean Strategy
- Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement) Blue Ocean Strategy
- "Make Mine a Russian Short-Hair, and Hold The Allergies, Please." Blue Ocean Strategy
Previuos Article
- Making the Case Blue Ocean Strategy
- Joe Smith's Closing Analysis (B) Blue Ocean Strategy
- Joe Smith's Closing Analysis (A), Spanish Version Blue Ocean Strategy
- GMAC: The Pipeline Blue Ocean Strategy
- On Writing Teaching Notes Well Blue Ocean Strategy
- Exxon Corp.: Trouble at Valdez Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (A) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (B) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (C) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (D) Blue Ocean Strategy
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire EssayPandas with BIG enough reputation.
Our Guarantees
- Quality assured
- Proof of no plagiarism
- Qualified writers
- Data security
- 24/7 support
- On time delivery
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!
Order Now